What will the future of cell culture process development look like? We delve into 3 of the most promising approaches to achieve Next Generation advances for cell and gene therapy.

What does the future of the vaccine look like? Tony D’Amore and Yan-Ping Yang of Sanofi Pasteur take us through the ever-evolving vaccine development and manufacturing landscape.

What are the key challenges facing gene therapy commercialisation today, and how can the industry best overcome them? This Insight Article delves into the top 3 strategies needed to bring the next generation of advanced therapeutics to the market and get ahead of the game.

Arun Srivastava of the University of Florida’s takes us through the history of the AAV Vector development for Human Gene Therapy and analyses the critical role of his institution’s Division of Cellular and Molecular Therapy in the optimising and discovery of Next Generation AAVs.